Brooklyn ImmunoTherapeutics Stock Forecast, Price & News

Wall Street analysts have given Brooklyn ImmunoTherapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Brooklyn ImmunoTherapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Brooklyn ImmunoTherapeutics is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Brooklyn ImmunoTherapeutics.

Brooklyn ImmunoTherapeutics, Inc. (NYSEAMERICAN:BTX) posted its quarterly earnings data on Tuesday, August, 9th. The biotechnology company reported ($0.11) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.17) by $0.06. The biotechnology company had revenue of $1.27 million for the quarter, compared to analyst estimates of $1.75 million.
View Brooklyn ImmunoTherapeutics' earnings history.

Some companies that are related to Brooklyn ImmunoTherapeutics include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Alnylam Pharmaceuticals (ALNY), Exact Sciences (EXAS), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Novavax (NVAX), Repligen (RGEN), Neurocrine Biosciences (NBIX) and United Therapeutics (UTHR).
View all of BTX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Brooklyn ImmunoTherapeutics investors own include CA (CA), Asterias Biotherapeutics (AST), Geron (GERN), Micron Technology (MU), BlackRock (BLK), Endologix (ELGX), OPKO Health (OPK), Immunomedics (IMMU), Synergy Pharmaceuticals (SGYP) and Chipotle Mexican Grill (CMG).

Brooklyn ImmunoTherapeutics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BTX."

Shares of BTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BTX stock can currently be purchased for approximately $10.59.

Brooklyn ImmunoTherapeutics has a market capitalization of $452.03 million.

Brooklyn ImmunoTherapeutics employs 10 workers across the globe.

The official website for Brooklyn ImmunoTherapeutics is www.biotimeinc.com.

Brooklyn ImmunoTherapeutics is headquartered at 1010 Atlantic Ave Ste 102, ALAMEDA, CA 94501-1147, United States.

Brooklyn ImmunoTherapeutics' mailing address is 1010 Atlantic Ave Ste 102, ALAMEDA, CA 94501-1147, United States. The biotechnology company can be reached via phone at +1-510-5213390.